The life sciences industry and regulators around the world are facing many challenges in protecting the safety of patients. Poor visibility across the supply chain has led to proliferation of drug-related criminal activities such as drug counterfeiting, illegal diversion, and theft. It has also caused inefficiencies to surface across supply chain functions. This not only hampers the brand equity of pharmaceutical companies but also puts the life of patients in serious danger. Therefore, serialization laws are fast becoming mandates in many countries.
Parag Agrawal in his white paper discusses the various aspects of Counterfeiting menace.
Download the full paper by signing in